Pasithea Therapeutics Announces Pricing of $60 Million Public Offering of Common Stock GlobeNewswire November 28, 2025 Extends cash runway through at least the first half of 2028 Led by Vivo Capital, Janus Henderson Investors, Coastlands Capital, Columbia Threadneedle Investments, Adage Capital Partners, and Squadron Capital Management MIAMI, Nov. 28, 2025 (GLOBE NEWSWIRE) — Pasithea Therapeutics […]
CarMax, Inc. Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – KMX GlobeNewswire November 28, 2025 LOS ANGELES, Nov. 28, 2025 (GLOBE NEWSWIRE) — The DJS Law Group reminds investors of a class action lawsuit against CarMax, Inc. (“CarMax” or “the Company”) (NYSE: KMX) violations of §§10(b) and
Earlier this week, on behalf of the Honourable Mélanie Joly, Minister of Industry and Minister responsible for Canada Economic Development for Quebec Regions, Canadian Space Agency (CSA) President Lisa Campbell announced that the Government of Canada will invest a total of €407.71 million (representing approximately CAD$664.6million) in European Space Agency (ESA) programs. This figure includes
Munich, Germany, Nov. 28, 2025 (GLOBE NEWSWIRE) — DYWIDAG, a global leader in post-tensioning solutions, stay-cable systems and geotechnical engineering products, has announced strong financial and operational results for the third quarter of 2025. Year-to-date revenues increased 5.5% year on year, with Earnings Before Interest, Depreciation, Amortisation and Tax up by 3.9% in the period
DYWIDAG Reports Strong Q3 Performance and Advances Key Strategic Initiatives Company sees growth across core markets, expanded operations and continued project success GlobeNewswire November 28, 2025 Munich, Germany, Nov. 28, 2025 (GLOBE NEWSWIRE) — DYWIDAG, a global leader in post-tensioning solutions, stay-cable systems and geotechnical engineering products, has announced strong financial and operational results for
Boca Raton, FL, Nov. 28, 2025 (GLOBE NEWSWIRE) — In a new article titled “The Hidden Hiring Crisis No One Is Talking About: Why Clarity, Not Candidates, Is Your Biggest Problem in 2025,” hiring expert Andrea Hoffer argues that most small-to-mid size businesses are not failing to hire because candidates won't apply — they're failing
(TSX-V:NRX),(Frankfurt:J90),(Boerse Stuttgart – Freiverkehr:J90),(Boerse Muenchen – Freiverkehr:J90),(OTC US:NRXBF),(Other OTC:NRXBF), TORONTO and HAIFA, Israel, Nov. 28, 2025 (GLOBE NEWSWIRE) — NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company“), a preclinical-stage biotechnology company pioneering exosome-based therapies for central nervous system injuries, is pleased to announce its financial results for the third quarter
MALMÖ, SE / ACCESS Newswire / November 28, 2025 / Ascelia Pharma (STO:ACE) During the month of November, the number of shares and votes in Ascelia Pharma AB have changed due to conversion of a total of 53,335 series C shares into a total of 53,335 ordinary shares for delivery of shares to participants in
NEW YORK, NY / ACCESS Newswire / November 28, 2025 / Gold has always been the world’s confidence asset. People buy it because they trust it. Banks vault it because they believe it is pure. Exchanges trade it because they assume its origin is legitimate. That belief held for centuries because no one had a
NurExone Biologic Inc. Announces Third Quarter 2025 Financial Results and Provides Corporate Update GlobeNewswire November 28, 2025 TORONTO and HAIFA, Israel, Nov. 28, 2025 (GLOBE NEWSWIRE) — NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company“), a preclinical-stage biotechnology company pioneering exosome-based therapies for central nervous system injuries, is pleased to